Single Drug regimen for Carcinoma Esophagus which shows tumor size decrease of around 15-20% is:

Ans. (b) CisplatinRef: Sabiston 20th Edition, Page 1077* Cisplatin based chemotherapy has been used in those days as single drug regimen* The survival benefit of chemotherapy persisted at the updated median follow-up duration of 6 years, with 5-year survival rates of 23% with chemotherapy plus surgery and 17% with surgery alone.